Are we witnessing the demise of big pharma? Channel 4 News #pharma #recruiters

Posted On May 14 2017 by

#big pharma jobs # Like most websites Channel 4 uses cookies. In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. These cookies are completely safe and secure and will never contain any sensitive information. They are used only by Channel 4 or the trusted partners we work with. How to manage cookies In order to deliver an optimised service, Channel 4 uses cookies. These are simple text files which sit on your …


Are we witnessing the demise of big pharma? Channel 4 News #gland #pharma

Posted On Apr 27 2017 by

#big pharma jobs # Like most websites Channel 4 uses cookies. In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. These cookies are completely safe and secure and will never contain any sensitive information. They are used only by Channel 4 or the trusted partners we work with. How to manage cookies In order to deliver an optimised service, Channel 4 uses cookies. These are simple text files which sit on your …


Are we witnessing the demise of big pharma? Channel 4 News #pharmaceutical #healthcare #companies

Posted On Apr 20 2017 by

#big pharma jobs # Like most websites Channel 4 uses cookies. In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. These cookies are completely safe and secure and will never contain any sensitive information. They are used only by Channel 4 or the trusted partners we work with. How to manage cookies In order to deliver an optimised service, Channel 4 uses cookies. These are simple text files which sit on your …


Research – Development News Channel #msd #pharma

Posted On Apr 14 2017 by

#latest pharmaceutical news # Research Development News Channel Antibody reduces harmful brain amyloid plaques in Alzheimer’s patients Although the causes of Alzheimer’s disease are still unknown, it is clear that the disease commences with progressive amyloid deposition in the brains of affected persons between ten and fifteen years before the emergence of initial clinical symptoms such as memory loss. Researchers have now been able to show that Aducanumab, a human monoclonal antibody, selectively binds brain amyloid plaques, thus enabling microglial cells to remove the plaques. Last Updated: Saturday, 03 September 2016 Caffeine and its analogues revert memory deficits by normalizing …


Business – Industry News Channel #biggest #pharma #companies

Posted On Apr 10 2017 by

#latest pharmaceutical news # Business Industry News Channel Amgen obtains global development and commercial rights from Boehringer Ingelheim for investigational BiTE® immuno-oncology drug for multiple myeloma Amgen (NASDAQ:AMGN) and Boehringer Ingelheim today announced that Amgen has acquired global development and commercial rights from Boehringer Ingelheim for BI 836908 (AMG 420), a bispecific T cell engager (BiTE®) that targets B-cell maturation antigen (BCMA), a potential target for multiple myeloma. Last Updated: Friday, 02 September 2016 Saniona and Boehringer Ingelheim sign collaboration agreement in schizophrenia Boehringer Ingelheim, one of the world’s 20 leading pharmaceutical companies, and Saniona, a leading biotech company in …


Are we witnessing the demise of big pharma? Channel 4 News #d #pharma

Posted On Apr 9 2017 by

#big pharma jobs # Like most websites Channel 4 uses cookies. In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. These cookies are completely safe and secure and will never contain any sensitive information. They are used only by Channel 4 or the trusted partners we work with. How to manage cookies In order to deliver an optimised service, Channel 4 uses cookies. These are simple text files which sit on your …


Are we witnessing the demise of big pharma? Channel 4 News #pharma #magazine

Posted On Mar 31 2017 by

#big pharma jobs # Like most websites Channel 4 uses cookies. In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. These cookies are completely safe and secure and will never contain any sensitive information. They are used only by Channel 4 or the trusted partners we work with. How to manage cookies In order to deliver an optimised service, Channel 4 uses cookies. These are simple text files which sit on your …


Research – Development News Channel #schwartz #pharma

Posted On Mar 27 2017 by

#latest pharmaceutical news # Research Development News Channel Antibody reduces harmful brain amyloid plaques in Alzheimer’s patients Although the causes of Alzheimer’s disease are still unknown, it is clear that the disease commences with progressive amyloid deposition in the brains of affected persons between ten and fifteen years before the emergence of initial clinical symptoms such as memory loss. Researchers have now been able to show that Aducanumab, a human monoclonal antibody, selectively binds brain amyloid plaques, thus enabling microglial cells to remove the plaques. Last Updated: Saturday, 03 September 2016 Caffeine and its analogues revert memory deficits by normalizing …


Are we witnessing the demise of big pharma? Channel 4 News #outsourcing #pharma

Posted On Mar 17 2017 by

#big pharma jobs # Like most websites Channel 4 uses cookies. In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. These cookies are completely safe and secure and will never contain any sensitive information. They are used only by Channel 4 or the trusted partners we work with. How to manage cookies In order to deliver an optimised service, Channel 4 uses cookies. These are simple text files which sit on your …


Business – Industry News Channel #pharma #data

Posted On Feb 12 2017 by

#latest pharmaceutical news # Business Industry News Channel Amgen obtains global development and commercial rights from Boehringer Ingelheim for investigational BiTE® immuno-oncology drug for multiple myeloma Amgen (NASDAQ:AMGN) and Boehringer Ingelheim today announced that Amgen has acquired global development and commercial rights from Boehringer Ingelheim for BI 836908 (AMG 420), a bispecific T cell engager (BiTE®) that targets B-cell maturation antigen (BCMA), a potential target for multiple myeloma. Last Updated: Friday, 02 September 2016 Saniona and Boehringer Ingelheim sign collaboration agreement in schizophrenia Boehringer Ingelheim, one of the world’s 20 leading pharmaceutical companies, and Saniona, a leading biotech company in …